Initial Real-World Experience with Faricimab in Treatment-Resistant Neovascular Age-Related Macular Degeneration

PURPOSE: To evaluate the initial efficacy and safety of intravitreal faricimab in eyes previously treated for neovascular age-related macular degeneration (nARMD). PATIENTS AND METHODS: A retrospective review of all patients with nARMD previously treated with anti-vascular endothelial growth factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Leung, Ella H, Oh, Daniel J, Alderson, Shannon E, Bracy, Joshlynn, McLeod, Mia, Perez, Litzi I, Bottini, Alexander, Chin Yee, David, Mukkamala, Krishna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167970/
https://www.ncbi.nlm.nih.gov/pubmed/37181079
http://dx.doi.org/10.2147/OPTH.S409822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167970/
https://www.ncbi.nlm.nih.gov/pubmed/37181079
http://dx.doi.org/10.2147/OPTH.S409822

Ejemplares similares